TrialThe Lancet. Neurology2017
Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
David C Hess et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
229 papers cite itlatest 60 shown
this paperpooled ittrialcites it